advanced liver disease.
Serum ferritin - An independent prognostic marker in predicting early mortality in advanced liver disease.
118
Granulocyte Colony-Stimulating Factor Improves Deficient In Vitro Neutrophil Transendothelial Migration in Patients with Advanced Liver Disease
7
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
8
Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease
6
Validation of CLIF C ACLF score to define a threshold for futility of intensive care support for patients with acute on chronic liver failure
8
<p>Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives</p>
6
Systemic manifestations of hepatitis C infection
8
Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective
12
PubMedCentral-PMC4925189.pdf
15
LIVER HISTOLOGY IN ASYMPTOMATIC HEPATITIS-C VIRUS POSITIVE BLOOD DONORS
6
Results: Abnormality in blood pH was noted in 35(70%) patients. Alkalosis was commonest finding (40%)
6
Indications for Caesarean Section Among the Antenatal Cases Admitted In a Tertiary Care Hospital of Kollam, Kerala
5
Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study
7
Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D
18
Causes and Stages of Hepatocellular Carcinoma at Patient Presentation at a Tertiary Medical Center in Western Saudi Arabia
9
<p>Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes</p>
10
Frequency of Celiac Disease in Children Presented with Liver Disease at a Tertiary Care Center
5
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis
8
Autoimmune hepatitis in India: profile of an uncommon disease
8
<p>Efficacy of direct-acting antiviral therapy for hepatitis C viral infection. Real-life experience in Bahrain</p>
10